• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黄腐酚通过抑制BIG3-PHB2相互作用来抑制乳腺癌中的雌激素信号传导。

Xanthohumol suppresses oestrogen-signalling in breast cancer through the inhibition of BIG3-PHB2 interactions.

作者信息

Yoshimaru Tetsuro, Komatsu Masato, Tashiro Etsu, Imoto Masaya, Osada Hiroyuki, Miyoshi Yasuo, Honda Junko, Sasa Mitsunori, Katagiri Toyomasa

机构信息

Division of Genome Medicine, Institute for Genome Research, The University of Tokushima, Tokushima, Japan.

Department of Biosciences and Informatics, Faculty of Science and Technology, Keio University, Kanagawa, Japan.

出版信息

Sci Rep. 2014 Dec 8;4:7355. doi: 10.1038/srep07355.

DOI:10.1038/srep07355
PMID:25483453
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4258681/
Abstract

Xanthohumol (XN) is a natural anticancer compound that inhibits the proliferation of oestrogen receptor-α (ERα)-positive breast cancer cells. However, the precise mechanism of the antitumour effects of XN on oestrogen (E2)-dependent cell growth, and especially its direct target molecule(s), remain(s) largely unknown. Here, we focus on whether XN directly binds to the tumour suppressor protein prohibitin 2 (PHB2), forming a novel natural antitumour compound targeting the BIG3-PHB2 complex and acting as a pivotal modulator of E2/ERα signalling in breast cancer cells. XN treatment effectively prevented the BIG3-PHB2 interaction, thereby releasing PHB2 to directly bind to both nuclear- and cytoplasmic ERα. This event led to the complete suppression of the E2-signalling pathways and ERα-positive breast cancer cell growth both in vitro and in vivo, but did not suppress the growth of normal mammary epithelial cells. Our findings suggest that XN may be a promising natural compound to suppress the growth of luminal-type breast cancer.

摘要

黄腐酚(XN)是一种天然抗癌化合物,可抑制雌激素受体α(ERα)阳性乳腺癌细胞的增殖。然而,XN对雌激素(E2)依赖性细胞生长的抗肿瘤作用的确切机制,尤其是其直接靶分子,在很大程度上仍不清楚。在此,我们关注XN是否直接与肿瘤抑制蛋白抑制素2(PHB2)结合,形成一种靶向BIG3-PHB2复合物的新型天然抗肿瘤化合物,并作为乳腺癌细胞中E2/ERα信号传导的关键调节因子。XN处理有效地阻止了BIG3-PHB2相互作用,从而释放PHB2以直接结合核内和胞质中的ERα。这一事件导致E2信号通路和ERα阳性乳腺癌细胞在体外和体内的生长完全受到抑制,但不抑制正常乳腺上皮细胞的生长。我们的研究结果表明,XN可能是一种有前景的天然化合物,可抑制管腔型乳腺癌的生长。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/702d/4258681/7df7ef2dfc1c/srep07355-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/702d/4258681/9431e896bc57/srep07355-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/702d/4258681/ccad2f8f3a30/srep07355-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/702d/4258681/c4110131d00a/srep07355-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/702d/4258681/7df7ef2dfc1c/srep07355-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/702d/4258681/9431e896bc57/srep07355-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/702d/4258681/ccad2f8f3a30/srep07355-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/702d/4258681/c4110131d00a/srep07355-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/702d/4258681/7df7ef2dfc1c/srep07355-f4.jpg

相似文献

1
Xanthohumol suppresses oestrogen-signalling in breast cancer through the inhibition of BIG3-PHB2 interactions.黄腐酚通过抑制BIG3-PHB2相互作用来抑制乳腺癌中的雌激素信号传导。
Sci Rep. 2014 Dec 8;4:7355. doi: 10.1038/srep07355.
2
Stapled BIG3 helical peptide ERAP potentiates anti-tumour activity for breast cancer therapeutics.订书钉 BIG3 螺旋肽 ERAP 增强了乳腺癌治疗的抗肿瘤活性。
Sci Rep. 2017 May 12;7(1):1821. doi: 10.1038/s41598-017-01951-6.
3
BIG3 Inhibits the Estrogen-Dependent Nuclear Translocation of PHB2 via Multiple Karyopherin-Alpha Proteins in Breast Cancer Cells.BIG3通过多种核转运蛋白α蛋白抑制乳腺癌细胞中雌激素依赖的PHB2核转位。
PLoS One. 2015 Jun 8;10(6):e0127707. doi: 10.1371/journal.pone.0127707. eCollection 2015.
4
Therapeutic advances in BIG3-PHB2 inhibition targeting the crosstalk between estrogen and growth factors in breast cancer.针对乳腺癌中雌激素与生长因子相互作用的BIG3-PHB2抑制的治疗进展
Cancer Sci. 2015 May;106(5):550-8. doi: 10.1111/cas.12654. Epub 2015 Apr 1.
5
A-kinase anchoring protein BIG3 coordinates oestrogen signalling in breast cancer cells.A-激酶锚定蛋白 BIG3 协调乳腺癌细胞中的雌激素信号转导。
Nat Commun. 2017 May 30;8:15427. doi: 10.1038/ncomms15427.
6
Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells.靶向 BIG3-PHB2 相互作用以克服乳腺癌细胞对他莫昔芬的耐药性。
Nat Commun. 2013;4:2443. doi: 10.1038/ncomms3443.
7
Activation of an estrogen/estrogen receptor signaling by BIG3 through its inhibitory effect on nuclear transport of PHB2/REA in breast cancer.在乳腺癌中,BIG3通过对PHB2/REA核转运的抑制作用激活雌激素/雌激素受体信号通路。
Cancer Sci. 2009 Aug;100(8):1468-78. doi: 10.1111/j.1349-7006.2009.01209.x. Epub 2009 May 6.
8
The survival and proliferation of osteosarcoma cells are dependent on the mitochondrial BIG3-PHB2 complex formation.骨肉瘤细胞的存活和增殖依赖于线粒体BIG3-PHB2复合物的形成。
Cancer Sci. 2021 Oct;112(10):4208-4219. doi: 10.1111/cas.15099. Epub 2021 Aug 19.
9
Biophysical characterization of the breast cancer-related BIG3-PHB2 interaction: Effect of non-conserved loop region of BIG3 on the structure and the interaction.乳腺癌相关 BIG3-PHB2 相互作用的生物物理特性:BIG3 非保守环区对结构和相互作用的影响。
Biochem Biophys Res Commun. 2019 Oct 8;518(1):183-189. doi: 10.1016/j.bbrc.2019.08.028. Epub 2019 Aug 14.
10
Xanthohumol induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI3K/Akt/mTOR-kinase in human gastric cancer cells.黄腐酚通过半胱天冬酶激活、Bcl-2 调节以及抑制人胃癌细胞中的 PI3K/Akt/mTOR-激酶诱导细胞凋亡。
Biomed Pharmacother. 2018 Oct;106:1300-1306. doi: 10.1016/j.biopha.2018.06.166. Epub 2018 Jul 21.

引用本文的文献

1
Phytoconstituents as emerging therapeutics for breast cancer: Mechanistic insights and clinical implications.植物成分作为乳腺癌的新兴治疗手段:作用机制及临床意义
Cancer Pathog Ther. 2025 Feb 28;3(5):364-382. doi: 10.1016/j.cpt.2025.02.006. eCollection 2025 Sep.
2
Estrogenic Prenylated Flavonoids in .. 中的雌激素类苯丙素类黄酮
Genes (Basel). 2024 Feb 4;15(2):204. doi: 10.3390/genes15020204.
3
Semi-synthesis and in vitro anti-cancer effects evaluation of novel xanthohumol derivatives.新型黄腐酚衍生物的半合成及其体外抗癌效果评估

本文引用的文献

1
Immunolocalization of cell cycle proteins (p57, p27, cyclin D3, PCNA and Ki67) in intrauterine growth retardation (IUGR) and normal human term placentas.细胞周期蛋白(p57、p27、细胞周期蛋白D3、增殖细胞核抗原和Ki67)在宫内生长受限(IUGR)和正常足月人胎盘中的免疫定位。
Acta Histochem. 2014 Apr;116(3):493-502. doi: 10.1016/j.acthis.2013.10.007. Epub 2013 Nov 16.
2
Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells.靶向 BIG3-PHB2 相互作用以克服乳腺癌细胞对他莫昔芬的耐药性。
Nat Commun. 2013;4:2443. doi: 10.1038/ncomms3443.
3
Effect of xanthohumol and 8-prenylnaringenin on MCF-7 breast cancer cells oxidative stress and mitochondrial complexes expression.
Mol Divers. 2024 Oct;28(5):2749-2758. doi: 10.1007/s11030-023-10706-7. Epub 2023 Dec 8.
4
Pharmacokinetic and pharmacodynamic herb-drug interactions-part I. Herbal medicines of the central nervous system.药代动力学和药效学的草药-药物相互作用-第一部分。中枢神经系统的草药。
PeerJ. 2023 Nov 15;11:e16149. doi: 10.7717/peerj.16149. eCollection 2023.
5
Anticancer Potential of Natural Chalcones: In Vitro and In Vivo Evidence.天然查耳酮的抗癌潜力:体外和体内证据。
Int J Mol Sci. 2023 Jun 19;24(12):10354. doi: 10.3390/ijms241210354.
6
Natural Products for the Prevention, Treatment and Progression of Breast Cancer.用于预防、治疗和延缓乳腺癌进展的天然产物
Cancers (Basel). 2023 May 30;15(11):2981. doi: 10.3390/cancers15112981.
7
Essential Protein PHB2 and Its Regulatory Mechanisms in Cancer.必需蛋白 PHB2 及其在癌症中的调控机制。
Cells. 2023 Apr 21;12(8):1211. doi: 10.3390/cells12081211.
8
targets multiple aspects of oral carcinogenesis and it is a potential antitumor phytotherapy against tongue cancer growth.针对口腔癌发生的多个方面,它是一种针对舌癌生长的潜在抗肿瘤植物疗法。
Front Pharmacol. 2023 Jan 5;13:1098374. doi: 10.3389/fphar.2022.1098374. eCollection 2022.
9
The integrative bioinformatics approaches to predict the xanthohumol as anti-breast cancer molecule: Targeting cancer cells signaling PI3K and AKT kinase pathway.预测黄腐酚作为抗乳腺癌分子的整合生物信息学方法:靶向癌细胞中PI3K和AKT激酶信号通路
Front Oncol. 2022 Dec 15;12:950835. doi: 10.3389/fonc.2022.950835. eCollection 2022.
10
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment.肝细胞癌与微生物群:对临床管理和治疗的影响。
World J Hepatol. 2022 Jul 27;14(7):1319-1332. doi: 10.4254/wjh.v14.i7.1319.
黄腐酚和 8-异戊烯基柚皮素对 MCF-7 乳腺癌细胞氧化应激和线粒体复合物表达的影响。
J Cell Biochem. 2013 Dec;114(12):2785-94. doi: 10.1002/jcb.24627.
4
The AKT/NF-κB inhibitor xanthohumol is a potent anti-lymphocytic leukemia drug overcoming chemoresistance and cell infiltration.AKT/NF-κB 抑制剂黄腐酚是一种有效的抗淋巴细胞白血病药物,可克服化疗耐药性和细胞浸润。
Biochem Pharmacol. 2012 Jun 15;83(12):1634-42. doi: 10.1016/j.bcp.2012.03.006. Epub 2012 Mar 17.
5
Xanthohumol impairs autophagosome maturation through direct inhibition of valosin-containing protein.黄腐酚通过直接抑制含缬氨酸蛋白而损害自噬体成熟。
ACS Chem Biol. 2012 May 18;7(5):892-900. doi: 10.1021/cb200492h. Epub 2012 Mar 2.
6
Inhibitory effect of soluble platelet-derived growth factor receptor β on intraosseous growth of breast cancer cells in nude mice.可溶性血小板衍生生长因子受体 β 对裸鼠乳腺癌细胞骨内生长的抑制作用。
Cancer Sci. 2011 Oct;102(10):1904-10. doi: 10.1111/j.1349-7006.2011.02026.x. Epub 2011 Aug 3.
7
Aromatase, aromatase inhibitors, and breast cancer.芳香酶、芳香酶抑制剂与乳腺癌。
J Steroid Biochem Mol Biol. 2011 May;125(1-2):13-22. doi: 10.1016/j.jsbmb.2011.02.001. Epub 2011 Feb 16.
8
Clinical significance of estrogen receptor phosphorylation.雌激素受体磷酸化的临床意义。
Endocr Relat Cancer. 2011 Jan 19;18(1):R1-14. doi: 10.1677/ERC-10-0070. Print 2011 Feb.
9
Growth inhibitory and apoptosis-inducing effects of xanthohumol, a prenylated chalone present in hops, in human prostate cancer cells.黄腐酚,一种存在于啤酒花中的类异戊二烯物质,对人前列腺癌细胞的生长抑制和凋亡诱导作用。
Anticancer Res. 2010 Sep;30(9):3333-9.
10
New strategies in estrogen receptor-positive breast cancer.雌激素受体阳性乳腺癌的新策略。
Clin Cancer Res. 2010 Apr 1;16(7):1979-87. doi: 10.1158/1078-0432.CCR-09-1823. Epub 2010 Mar 23.